Studies on peptidases derived from probiotic bacteria, particularly those targeting gliadins, are a relatively new area of research, and the efficacy and specificity of these enzymes in degrading immunoreactive gliadin fragments associated with CD are still under investigation. Here, LAP3 is linked to Cowden disease.